UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between hepatitis (b & c) and liver cancer clinical trials and research opportunities
Hepatitis C is now curable with DAAs, but hepatitis B remains a chronic management challenge. UK elimination programmes drive trial activity.
Primary liver cancer (HCC) is rising in the UK, often secondary to cirrhosis. Immunotherapy combinations and locoregional therapies are key trial areas.
Hepatitis trials focus on cure/elimination (HCV) or functional cure (HBV). Liver cancer trials focus on systemic and local treatments for advanced disease.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
